Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 324561 - 324580 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Luxembourg | (L01FD01) trastuzumab | Trazimera PDRE SOLCC.PERF. 150 mg 1*1 flacon 150mg | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | n/a |
| Luxembourg | (L01FD01) trastuzumab | Herzuma PDRE SOLCC.PERF. 420 mg 1*1 flacon 420 g | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | n/a |
| Luxembourg | (L01FD01) trastuzumab | KANJINTI PDRE SOLCC.PERF. 420 mg 1*1 flacon | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | n/a |
| Luxembourg | (L01FD01) trastuzumab | Ogivri PDRE SOLCC.PERF. 420 mg 1*1 flacon (verre) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | n/a |
| Luxembourg | (L01FD01) trastuzumab | Ontruzant PDRE SOLCC.PERF. 420 mg 1*1 flacon 40 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | n/a |
| Luxembourg | (L01FD01) trastuzumab | Trazimera PDRE SOLCC.PERF. 420 mg 1*1 flacon 420 mg | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | n/a |
| Luxembourg | (L01FF02) pembrolizumab | KEYTRUDA SOLCC.PERF. 25 mg / 1 mL 1*1 flacon 4 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Endometrial Neoplasms | n/a |
| Luxembourg | (L01FF05) atezolizumab | Tecentriq SOLCC.PERF. 1200 mg 1*1 flacon 20 ml | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | n/a |
| Luxembourg | (L01FF05) atezolizumab | Tecentriq SOLCC.PERF. 840 mg 1*1 flacon 14 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | n/a |
| Luxembourg | (L01FG01) bevacizumab | Abevmy SOLCC.DSP. 25 mg / 1 mL 1*1 flacon 16 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | n/a |
| Luxembourg | (L01FG01) bevacizumab | Abevmy SOLCC.DSP. 25 mg / 1 mL 1*1 flacon 4 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | n/a |
| Luxembourg | (L01FG01) bevacizumab | MVASI SOLCC.DSP. 25 mg / 1 mL 1*1 flacon 16 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Peritoneal Neoplasms;Ovarian Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Fallopian Tube Neoplasms | n/a |
| Luxembourg | (L01FG01) bevacizumab | MVASI SOLCC.DSP. 25 mg / 1 mL 1*1 flacon 4 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Peritoneal Neoplasms;Ovarian Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Fallopian Tube Neoplasms | n/a |
| Luxembourg | (L01FG01) bevacizumab | VEGZELMA SOLCC.PERF. 25 mg / 1 mL 1*1 flacon 16 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | n/a |
| Luxembourg | (L01FG01) bevacizumab | VEGZELMA SOLCC.PERF. 25 mg / 1 mL 1*1 flacon 4 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | n/a |
| Luxembourg | (L01FG01) bevacizumab | Zirabev SOLCC.PERF. 25 mg / 1 mL 1*1 flacon 16 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | n/a |
| Luxembourg | (L01FG01) bevacizumab | Zirabev SOLCC.PERF. 25 mg / 1 mL 1*1 flacon 4 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | n/a |
| Luxembourg | (L01FX08) elotuzumab | Empliciti PDRE SOLCC.SOL.PERF. 300 mg 1*1 flacon (verre) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | n/a |
| Luxembourg | (L01FX08) elotuzumab | Empliciti PDRE SOLCC.SOL.PERF. 400 mg 1*1 flacon (verre) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | n/a |
| Luxembourg | (L01FX14) polatuzumab vedotin | Polivy PDRE SOLCC.PERF. 140 mg 1*1 flacon (verre) | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, B-Cell | n/a |
Pages
